Learn
This week in psychedelic business news, Canada expands legal distribution for psychedelics, therapeutic DMT stroke treatment, and more....
Are the subjective effects - that is, the psychedelic trip itself - fundamental for therapeutic outcomes? New research explores....
Numinus Biosciences has received expanded regulatory approval in Canada for psychedelic use and distribution....
Algernon Pharmaceuticals is exploring the little-researched psychedelic substance DMT to see if it has potential in treating stroke patients....
New research is looking at ketamine therapy as a potential aid in slowing the deadly disease ALS, amyotrophic lateral sclerosis....
Core One Labs is exploring DMT therapy for anxiety and depression in a partnership with Ketamine Infusion Centers....
A new study is looking at how psilocybin treatment may help to reduce debilitating short-lasting unilateral neuralgiform headache attacks....
Tony White may have lost his battle with cancer, but becoming the first end of life recipient of psilocybin treatment...
New research is looking at psilocybin truffles as a potential anti-aging tool and aid in treating age-related psychiatric disorders....
Lumenate is an app that simulates a psychedelic experience without the need for illegal substances....